CVS Shares Plunge in Volume to 297th as Trading Slumps 23.12%

On September 24, 2025, CVS Health Corporation (CVS) traded with a volume of $350 million, reflecting a 23.12% decline from the previous day's trading activity. The stock closed at a 0.16% decline, ranking 297th in volume among listed equities for the session.

Recent developments impacting the pharmacy giant include ongoing regulatory scrutiny over prescription drug pricing practices. A federal investigation into potential antitrust violations has intensified in recent weeks, with regulators examining pricing disparities across generic medications. While no formal charges have been announced, legal risks remain elevated as the probe progresses.

CVS's recent partnership with a national health insurer to expand telehealth services has also drawn market attention. The collaboration aims to integrate virtual care platforms with retail pharmacy operations, though analysts note implementation timelines remain unclear. Investors appear cautious about near-term profitability implications from these initiatives.

To run this back-test rigorously, I need to confirm standard parameters: The investment universe would include all NYSE/NASDAQ/AMEX-listed stocks with continuous trading from 2022-01-03 to 2025-09-24. Daily rebalancing would select the 500 highest-volume names by dollar value, with purchases executed at open and held until close. Portfolio performance will be calculated without transaction cost adjustments. Please confirm if these settings meet requirements or specify adjustments.